Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1981;64:297-305

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruberman, W.
Right arrow Articles by Shapiro, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruberman, W.
Right arrow Articles by Shapiro, S.

Circulation, Vol 64, 297-305, Copyright © 1981 by American Heart Association


ARTICLES

Ventricular premature complexes and sudden death after myocardial infarction

W Ruberman, E Weinblatt, JD Goldberg, CW Frank, BS Chaudhary and S Shapiro

Among 1739 male survivors of myocardial infarction, mortality over 5 years was examined in relation to presence of complex ventricular premature complexes (R on T, runs of two or more, multiform or bigeminal complexes) identified during 1 hour of monitoring. Such arrhythmia was associated with excess risk of death over the entire period. Men with R on T or runs during the hour show a 5-year sudden coronary death rate of 25%, compared with 6% of men free of premature complexes. Men with complex ventricular premature complexes are also at relatively higher risk for nonsudden cardiac death than the other men (5-year mortality 15% and 7%, respectively), but no additional disadvantage was associated with the presence of R on T or runs. Multivariate survival analyses, controlling simultaneously for other important clinical factors, identify complex ventricular premature complexes as the strongest influence on risk of sudden coronary death and congestive heart failure as the strongest influence on risk of other cardiac death.


This article has been cited by other articles:


Home page
EuropaceHome page
M. M. Gallagher, M. Padula, M. Sgueglia, L. Santini, P. Voci, N. G. Mahon, Y. G. Yap, and F. Romeo
Electrocardiographic markers of structural heart disease and predictors of death in 2332 unselected patients undergoing outpatient Holter recording
Europace, December 1, 2007; 9(12): 1203 - 1208.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. N. Sabir, M. J. Killeen, C. A. Goddard, G. Thomas, S. Gray, A. A. Grace, and C. L.-H. Huang
Transient alterations in transmural repolarization gradients and arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts
J. Physiol., May 15, 2007; 581(1): 277 - 289.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
J. J. Bailey, M. Hodges, and T. R. Church
Decision to Implant a Cardioverter Defibrillator after Myocardial Infarction: The Role of Ejection Fraction v. Other Risk Factor Markers
Med Decis Making, March 1, 2007; 27(2): 151 - 160.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
HeartHome page
G A Lanza, D Cianflone, A G Rebuzzi, G Angeloni, A Sestito, G Ciriello, G La Torre, F Crea, A Maseri, and for the Stratificazione Prognostica dell'Angina In
Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina
Heart, August 1, 2006; 92(8): 1055 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Bailey, A. S. Berson, H. Handelsman, and M. Hodges
Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction
J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1902 - 1911.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. D. Sanders, M. A. Hlatky, N. R. Every, K. M. McDonald, P. A. Heidenreich, L. S. Parsons, and D. K. Owens
Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction
Ann Intern Med, November 20, 2001; 135(10): 870 - 883.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. V. Huikuri, A. Castellanos, and R. J. Myerburg
Sudden Death Due to Cardiac Arrhythmias
N. Engl. J. Med., November 15, 2001; 345(20): 1473 - 1482.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Elam and V. Macefield
Multiple firing of single muscle vasoconstrictor neurons during cardiac dysrhythmias in human heart failure
J Appl Physiol, August 1, 2001; 91(2): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. A Karle, V. A.W Kreye, D. Thomas, K. Rockl, S. Kathofer, W. Zhang, and J. Kiehn
Antiarrhythmic drug carvedilol inhibits HERG potassium channels
Cardiovasc Res, February 1, 2001; 49(2): 361 - 370.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. Irvine, A. Basinski, B. Baker, S. Jandciu, M. Paquette, J. Cairns, S. Connolly, R. Roberts, M. Gent, and P. Dorian
Depression and Risk of Sudden Cardiac Death After Acute Myocardial Infarction: Testing for the Confounding Effects of Fatigue
Psychosom Med, November 1, 1999; 61(6): 729 - 737.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Andresen, G. Steinbeck, T. Bruggemann, D. Muller, R. Haberl, S. Behrens, E. Hoffmann, K. Wegscheider, R.u. Dissmann, and H.-C. Ehlers
Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 131 - 138.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Jensen-Urstad, F Bouvier, B Saltin, and M Jensen-Urstad
High prevalence of arrhythmias in elderly male athletes with a lifelong history of regular strenuous exercise
Heart, February 1, 1998; 79(2): 161 - 164.
[Abstract] [Full Text]


Home page
CirculationHome page
M. J. Domanski, D. P. Zipes, and E. Schron
Treatment of Sudden Cardiac Death : Current Understandings From Randomized Trials and Future Research Directions
Circulation, June 17, 1997; 95(12): 2694 - 2699.
[Full Text]


Home page
CirculationHome page
C. M. Pratt, P. S. Greenway, M. H. Schoenfeld, M. L. Hibben, and J. A. Reiffel
Exploration of the Precision of Classifying Sudden Cardiac Death : Implications for the Interpretation of Clinical Trials
Circulation, February 1, 1996; 93(3): 519 - 524.
[Abstract] [Full Text]


Home page
Journal of Pharmacy PracticeHome page
E. J. Stanek, M. D. Schoen, and J. L. Bauman
Issues in the Treatment of Ventricular Ectopy: Past, Present, and Future Controversy
Journal of Pharmacy Practice, January 1, 1990; 3(5): 283 - 294.
[PDF]